Abstract | BACKGROUND: METHODS: Forty-one patients with a diagnosis of Morton's neuroma were randomized to receive 3 injections of either a corticosteroid plus a local anesthetic or a local anesthetic alone. The patients and the researcher who collected data were blinded to the treatment groups. The visual analog scale for pain and the American Orthopaedic Foot & Ankle Score (metatarsophalangeal/interphalangeal score) were obtained at baseline, after each injection, and at 3 and 6 months after the last injection. RESULTS: There were no significant between-group differences in terms of pain and function improvement at 3 and 6 months after treatment completion in comparison with baseline values. At the end of the study, 17 (48.5%) patients requested surgical excision of the neuroma: 7 (44%) in the experimental group and 10 (53%) in the control group ( P = 1.0). CONCLUSION: LEVEL OF EVIDENCE: Level I, randomized controlled trial.
|
Authors | Xavier Lizano-Díez, Alberto Ginés-Cespedosa, Eduard Alentorn-Geli, Daniel Pérez-Prieto, Gemma González-Lucena, Carlo Gamba, Santiago de Zabala, Alberto Solano-López, Pau Rigol-Ramón |
Journal | Foot & ankle international
(Foot Ankle Int)
Vol. 38
Issue 9
Pg. 944-951
(Sep 2017)
ISSN: 1944-7876 [Electronic] United States |
PMID | 28617064
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adrenal Cortex Hormones
(pharmacology, therapeutic use)
- Humans
- Morton Neuroma
(physiopathology, surgery)
- Neuroma
(surgery)
- Orthopedics
- Peripheral Nervous System Neoplasms
(drug therapy)
- Prospective Studies
- Randomized Controlled Trials as Topic
- Retrospective Studies
|